Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone vs Duloxetine for Painful Chemotherapy-Induced Peripheral Neuropathy
NCT05786599Phase 3Recruiting
- Sponsor
- University of British Columbia
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methadone in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by University of British Columbia. Started Mar 2025; status: recruiting.
02
Drugs
methadone
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT05786599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05786599.